M. T. Ergin

发表

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.

J. Ozols, H. Yamase, N. Chakraborty, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Imaging pattern of previously in vitro sensitized and interleukin-2 expanded autologous lymphocytes in human cancer.

R. P. Spencer, B. Mukherji, R. Kalish, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Biodistribution of IN-111 labeled tumor sensitized autologous lymphocytes in cancer patients.

R. P. Spencer, B. Mukherji, M. T. Ergin, 1987, Progress in clinical and biological research.

Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines.

L. Li, S. Kurtzman, N. Chakraborty, 1999, Journal of immunology.

Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma

S. Kurtzman, H. Yamase, N. Chakraborty, 1998, Cancer Immunology, Immunotherapy.

Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2

G. Robbins, R. Cable, B. Mukherji, 1993, Cancer Immunology, Immunotherapy.

Cell-Based Tumor Vaccines Implications in Designing Antigen-Presenting Antigen-Presenting Cells In Vitro: Response to Repetitive Stimulation with T Cell + Emergence of Regulatory CD4

S. Kurtzman, N. Chakraborty, B. Mukherji, 1999 .

Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine.

S. Kurtzman, N. Chakraborty, B. Mukherji, 1996, Cancer research.

Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.

N. Chakraborty, B. Mukherji, J. Sporn, 1991, Clinical immunology and immunopathology.

Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.

B. Mukherji, M. T. Ergin, A. Guha, 1986, Journal of immunology.

Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer.

B. Mukherji, M. T. Ergin, A. Guha, 1987, Journal of immunology.

Analysis of cytolytic effector cell response in vitro against autologous human tumor cells genetically altered to synthesize interleukin-2.

P. Stabach, B. Mukherji, S. Padula, 1993, Immunology letters.

Use of a cardiac phantom for intersystem survey.

R. P. Spencer, J. Mathews, M. T. Ergin, 1985 .

Thyroid carcinoma metastatic to pituitary.

R. P. Spencer, J. Mathews, M. T. Ergin, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response.

D. Twardzik, K. Hellstrom, N. Chakraborty, 1990, Journal of immunology.

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

N. Chakraborty, B. Mukherji, J. Sporn, 1989, The Journal of experimental medicine.

Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.

B. Mukherji, M. T. Ergin, A. Guha, 1986, Journal of immunology.

Suppressor cell activities in autologous human tumor systems. Suppression of tumor immunity.

B. Mukherji, M. T. Ergin, A. Guha, 1986, Archives of surgery.